Cargando…
CHI3L1 promotes tumor progression by activating TGF-β signaling pathway in hepatocellular carcinoma
CHI3L1 (YKL40) is a secreted glycoprotein and elevated serum CHI3L1 level has been proved to be associated with poor prognosis in many human cancers. However, the mechanism of how CHI3L1 causes poor prognosis in cancers is still unknown. Here, considering that CHI3L1 is a liver specific/enriched pro...
Autores principales: | Qiu, Qing-Chong, Wang, Lin, Jin, Shan-Shan, Liu, Guan-Feng, Liu, Jie, Ma, Liang, Mao, Rui-Fang, Ma, Ying-Ying, Zhao, Na, Chen, Ming, Lin, Biao-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177412/ https://www.ncbi.nlm.nih.gov/pubmed/30301907 http://dx.doi.org/10.1038/s41598-018-33239-8 |
Ejemplares similares
-
POH1 contributes to hyperactivation of TGF-β signaling and facilitates hepatocellular carcinoma metastasis through deubiquitinating TGF-β receptors and caveolin-1
por: Wang, Boshi, et al.
Publicado: (2019) -
Dysregulated glucuronic acid metabolism exacerbates hepatocellular carcinoma progression and metastasis through the TGFβ signalling pathway
por: Gao, Qingzhu, et al.
Publicado: (2022) -
High Expression of TGF-β1 Contributes to Hepatocellular Carcinoma Prognosis via Regulating Tumor Immunity
por: Jin, Xiuli, et al.
Publicado: (2022) -
Corrigendum to “Dysregulated glucuronic acid metabolism exacerbates hepatocellular carcinoma progression and metastasis through the TGFβ signalling pathway”
por: Gao, Qingzhu, et al.
Publicado: (2023) -
RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2
por: Wang, Xia, et al.
Publicado: (2021)